ARTICLE | Clinical News
Axiron testosterone regulatory update
December 6, 2010 8:00 AM UTC
FDA approved an NDA from Acrux for Axiron testosterone as replacement therapy in men for conditions associated with a deficiency or absence of testosterone, including primary and hypogonadotropic hypo...